Indication expansions and new products drug pipeline worldwide 2020
As of June 2020, 48 percent of the global drug pipeline was for new products, whereas 52 percent of the pipeline focused on indication expansions. This statistic shows the share of indication expansions and new products in the global drug pipeline as of June 2020.